1. Home
  2. UNFI vs NRIX Comparison

UNFI vs NRIX Comparison

Compare UNFI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Natural Foods Inc.

UNFI

United Natural Foods Inc.

N/A

Current Price

$53.37

Market Cap

2.8B

ML Signal

N/A

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

N/A

Current Price

$13.93

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNFI
NRIX
Founded
1976
2009
Country
United States
United States
Employees
23431
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
UNFI
NRIX
Price
$53.37
$13.93
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
★ $52.72
$33.50
AVG Volume (30 Days)
444.6K
★ 3.3M
Earning Date
12-08-2026
10-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 168.72
N/A
EPS
1.34
★ 3.26
Revenue
N/A
★ $76,987,000.00
Revenue This Year
$1.25
$786.93
Revenue Next Year
$2.50
N/A
P/E Ratio
$38.81
★ $4.37
Revenue Growth
N/A
★ 99.31
52 Week Low
$30.91
$14.01
52 Week High
$57.02
$28.23

Technical Indicators

Market Signals
Indicator
UNFI
NRIX
Relative Strength Index (RSI) 69.17 22.74
Support Level $44.57 N/A
Resistance Level $57.02 $17.47
Average True Range (ATR) 1.89 1.12
MACD 0.58 -0.63
Stochastic Oscillator 96.79 0.15

Price Performance

Historical Comparison
UNFI
NRIX

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic, and specialty foods and nonfood products across the United States and Canada. The company's products consist of national, regional, and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's reportable segments are: Natural (its maximum revenue-generating segment), Retail, and Conventional.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: